HuGE Literature Finder
Records 1-21
|
Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia.
Human psychopharmacology 2020 May e2737. Fedorenko Olga Yu, Paderina Diana Z, Loonen Anton J M, Pozhidaev Ivan V, Boiko Anastasiia S, Kornetova Elena G, Bokhan Nikolay A, Wilffert Bob, Ivanova Svetlana |
|
The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).
Psychiatria Danubina 2018 Jun 30 (2): 157-163. Kurylev Alexey A, Brodyansky Vadim M, Andreev Boris V, Kibitov Alexander O, Limankin Oleg V, Mosolov Sergey |
|
Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia.
Revista latino-americana de enfermagem 2018 26 e2983. Pinto Jeizziani Aparecida Ferreira, Freitas Pedro Henrique Batista de, Nunes Fernanda Daniela Dorneles, Granjeiro Paulo Afonso, Santos Luciana Lara Dos, Machado Richardson Miran |
|
[A role of interactions between N-methyl-D-aspartate and dopamine receptors in facial emotion recognition impairment in schizophrenia].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2017 117 (6): 47-52. Alfimova M V, Golimbet V E, Korovaitseva G I, Lezheiko T V, Tikhonov D V, Ganisheva T K, Berezin N B, Snegireva A A, Shemiakina T |
|
Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.
PloS one 2017 12 (1): e0170147. Nkam Irene, Ramoz Nicolas, Breton Florence, Mallet Jasmina, Gorwood Philip, Dubertret Caroli |
|
Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
Journal of psychiatric research 2016 Nov 86 9-17. Eisenstein Sarah A, Bogdan Ryan, Chen Ling, Moerlein Stephen M, Black Kevin J, Perlmutter Joel S, Hershey Tamara, Barch Deanna |
|
Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
Synapse (New York, N.Y.) 2016 May . Eisenstein Sarah A, Bogdan Ryan, Love-Gregory Latisha, Corral-Frías Nadia S, Koller Jonathan M, Black Kevin J, Moerlein Stephen M, Perlmutter Joel S, Barch Deanna M, Hershey Tama |
|
Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.
Psychopharmacology 2015 Jan 232 (1): 145-54. Bishop Jeffrey R, Reilly James L, Harris Margret S H, Patel Shitalben R, Kittles Rick, Badner Judith A, Prasad Konasale M, Nimgaonkar Vishwajit L, Keshavan Matcheri S, Sweeney John |
|
Association between ANKK1 (rs1800497) and LTA (rs909253) Genetic Variants and Risk of Schizophrenia.
BioMed research international 2015 2015 821827. Arab Arwa H, Elhawary Nasser |
|
Identification of ANKK1 rs1800497 variant in schizophrenia: new data and meta-analysis.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2014 Oct 165B (7): 564-71. Zhang Chen, Zhang Jiangtao, Fan Juan, Cheng Wenhong, Du Yasong, Yu Shunying, Fang Yi |
|
Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism.
Progress in neuro-psychopharmacology & biological psychiatry 2014 Aug 53 123-8. Kunii Yasuto, Miura Itaru, Matsumoto Junya, Hino Mizuki, Wada Akira, Niwa Shin-ichi, Nawa Hiroyuki, Sakai Miwako, Someya Toshiyuki, Takahashi Hitoshi, Kakita Akiyoshi, Yabe Hiroo |
|
Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012 Nov 15 (10): 1427-40. Völter Christoph, Riedel Michael, Wöstmann Nicola, Aichert Désirée S, Lobo Sarah, Costa Anna, Schmechtig Anne, Collier David A, Hartmann Annette M, Giegling Ina, Möller Hans-Jürgen, Quednow Boris B, Rujescu Dan, Kumari Veena, Ettinger Ulri |
|
Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.
The Journal of clinical psychiatry 2012 Aug 73 (8): 1077-86. Houston John P, Kohler Jared, Bishop Jeffrey R, Ellingrod Vicki L, Ostbye Katherine M, Zhao Fangyi, Conley Robert R, Poole Hoffmann Vicki, Fijal Bonnie |
|
Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.
Pharmacological reports : PR 2012 64 (3): 528-35. Tybura Piotr, Samochowiec Agnieszka, Beszlej Aleksander, Grzywacz Anna, Mak Monika, Frydecka Dorota, Bie?kowski Przemys?aw, Mierzejewski Pawe?, Potemkowski Andrzej, Samochowiec Jer |
Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample.
Alcoholism, clinical and experimental research 2011 May 35 (5): 963-75. Kendler Kenneth S, Kalsi Gursharan, Holmans Peter A, Sanders Alan R, Aggen Steven H, Dick Danielle M, Aliev Fazil, Shi Jianxin, Levinson Douglas F, Gejman Pablo |
|
Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 Oct 30 (42): 14205-12. Stelzel Christine, Basten Ulrike, Montag Christian, Reuter Martin, Fiebach Christian |
|
A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.
Progress in neuro-psychopharmacology & biological psychiatry 2010 Apr 34 (3): 492-9. Dubertret Caroline, Bardel Claire, Ramoz Nicolas, Martin Pierre-Marie, Deybach Jean-Charles, Adès Jean, Gorwood Philip, Gouya Laure |
|
Genetic diagnostics of functional variants of the human dopamine D2 receptor gene.
Psychiatric genetics 2009 Oct 19 (5): 259-68. Doehring Alexandra, Kirchhof Anja, Lötsch Jö |
|
Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
Journal of psychiatric research 2009 Mar 43 (6): 600-6. Shen Yu-Chih, Chen Shih-Fen, Chen Chia-Hsiang, Lin Chaucer C H, Chen Shaw-Ji, Chen Yu-Jung, Luu Sy-Ue |
|
A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate.
Psychiatric genetics 2007 Jun 17 (3): 159-63. Parsons Michael J, Mata Ignacio, Beperet Maria, Iribarren-Iriso Fernando, Arroyo Barbara, Sainz Ricardo, Arranz Maria J, Kerwin Robe |
|
Association of Candidate Single Nucleotide Polymorphisms Related to Candidate Genes in Patients With Schizophrenia.
Basic and clinical neuroscience 0 11 (5): 595-608. Karimian Seyedeh Sara, Akbari Mohammad Taghi, Sadr Seyed Saeed, Javadi Gholamre |
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 23, 2021
- Content source: